NT-pro BNP and diastolic dysfunction by echocardiography predicts cardiovascular outcomes in patients with heart failure and preserved systolic function

被引：0
|
作者：
Grewal, J. [1 ]
Mckelvie, R. [1 ]
Persson, H. [2 ]
Tait, P. [2 ]
Carlsson, J. [3 ]
Swedberg, K. [4 ]
Ostergren, J. [5 ]
Lonn, E. [4 ]
机构：
[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[2] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden
[3] AstraZeneca R&D, Molndal, Sweden
[4] Sahlgrens Univ Hosp, Gothenburg, Sweden
[5] Karolinska Inst, Solna, Sweden
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [1] NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure
    Pfister, R.
    Mueller-Ehmsen, J.
    Hagemeister, J.
    Hellmich, M.
    Erdmann, E.
    Schneider, C. A.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (06) : 467 - 472
  • [2] Serum Levels of NT- pro ANP, BNP, NT-pro BNP and Function of the Left Atrium in Patients with Heart Failure and Preserved Ejection Fraction after Myocardial Infarction
    Shurupov, V.
    Suslova, T.
    Ryabov, V.
    NEW OPERATIONAL TECHNOLOGIES (NEWOT'2015), 2015, 1688
  • [3] RETRACTED: The Value of Echocardiography Combined with NT-pro BNP Level in Assessment and Prognosis of Diastolic Heart Failure (Retracted Article)
    Chen, Shaolei
    Zhou, Yanli
    Wu, Xia
    Shi, Shaojun
    Wu, Haiyan
    Li, Peng
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [4] BNP/ NT-pro BNP thresholds for the assessment of the prognosis in patients without heart failure
    Hendricks, S.
    Mahabadi, A. A.
    Vogel, L.
    Al-Rashid, F.
    Luedike, P.
    Totzeck, M.
    Rassaf, T.
    Dykun, I.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2504 - 2504
  • [5] NT-pro BNP predicts toleration of beta-blocker therapy in patients with chronic heart failure
    Johnston, N
    Green, M
    Robb, S
    Morton, I
    Dargie, H
    EUROPEAN HEART JOURNAL, 2002, 23 : 270 - 270
  • [6] NT-Pro BNP: biomarker for monitoring of clinical status and as a prognostic marker in ambulatory patients with systolic heart failure
    Valverde, Marcelo
    Acle, Santiago
    Ormaechea, Gabriela
    Alvarez, Pablo
    INSUFICIENCIA CARDIACA, 2013, 8 (02) : 59 - 69
  • [7] BNP and Nt-pro BNP as new markers of cardiac dysfunction in patients with shock
    Baixas, C
    Pathak, A
    Garrigues, E
    Mucke, F
    Roncalli, J
    Puel, J
    Genestal, M
    Galinier, M
    CIRCULATION, 2003, 108 (17) : 317 - 317
  • [8] Plasma NT-pro BNP concentrations are associated with ambulatory blood pressure in black hypertensive patients with normal systolic function on echocardiography
    Libhaber, EN
    Abbasi, H
    Toyin, CA
    Norton, GR
    Woodiwiss, A
    Libhaber, CD
    Essop, MR
    Sliwa, K
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 37A - 37A
  • [9] Acute Heart Failure: The Validity of NT-pro BNP varies by Subgroup
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (21)
  • [10] Evolution of NT-pro BNP levels in heart transplanted patients
    Sepulveda, L
    Aldunate, J
    Llancaqueo, M
    Tong, AM
    Vial, MJ
    CLINICAL CHEMISTRY, 2005, 51 : A126 - A126
12345